Concepedia

Publication | Closed Access

Conversion to Sirolimus as Primary Immunosuppression Attenuates the Progression of Allograft Vasculopathy After Cardiac Transplantation

DOI

177

Citations

38

References

2007

Year

Eugenia Raichlin, Jang‐Ho Bae, Zain Khalpey, Brooks S. Edwards, Walter K. Kremers, Alfredo L. Clavell, Richard J. Rodeheffer, Robert P. Frantz, Charanjit S. Rihal, Amir Lerman,
Circulation

Abstract

Substituting CNI with SRL as primary immunosuppression attenuates cardiac allograft vasculopathy progression.

References

YearCitations

Page 1